Articles

As tech layoffs mount, communities on LinkedIn are trying to find jobs for affected workers

“People will cross-post opportunities within the group that they believe others could benefit from, people in the group are keen to share opportunities for others.”

The bulls are fighting off challengers for control of the stock market

Signs of weakness are evident but are having little impact so far.

Cloudflare’s stock catapults higher as earnings beat captures ‘robust momentum’

Cloudflare shares surged 8% in Thursday’s regular session and were poised to tack on further gains after earnings.

Expedia spooks investors with CEO change

Expedia Group Inc. shares fell 12% in the extended session Thursday, as investors appeared nervous about a CEO change and looked past a quarterly beat for the online travel company.

S&P 500 touches 5,000 for first time, but fails to close above milestone

The stock-market rally briefly carries the S&P 500 above 5,000 points for the first time.

China’s consumers are buying more luxury clothes even as the economy struggles

China’s broader economy may be struggling, but that doesn’t seem to be stopping consumers there from splurging on more luxury clothes.

Does Viagra really help prevent Alzheimer’s? Not so fast.

“The study does not prove that erectile dysfunction drugs reduce the risk of Alzheimer’s disease,” the American Academy of Neurology said. “It only shows an association.”

Affirm beats on earnings, but stock pulls back after a sharp rally

Shares of Affirm were down about 6% in after-hours trading after soaring 10% during the regular session.

Pinterest’s stock takes a hit after revenue miss

Pinterest Inc.’s stock initially plummeted 23% before rallying in extended trading Thursday after it reported a revenue miss.

Here’s the investor playbook for making money in commercial real estate as Fed delays rate cuts

What was novel four decades ago suddenly looks relevant again for the reeling U.S. commercial-real-estate industry.

J&J, Merck and Bristol Myers CEOs, under fire on Capitol Hill, seek to turn up heat on drug-market middlemen 

Drugmakers grilled on the cost of prescription drugs on Capitol Hill Thursday sought to deflect the criticism onto drug-market middlemen who they said are pushing list prices for medications higher.

Corn and soybean prices drop 8% to begin 2024 — and the EPA is partly to blame

Corn and soybean futures are falling, with disappointing U.S. mandates for plant-based renewable fuels contributing to weakness.
1 793 794 795 796 797 1,630